Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Shanghai CirCode Biomed Co. Ltd.
October 23, 2025
Shanghai CirCode Biomed Co. Ltd.
Orphan Drug Designation
FDA orphan drug designation: treatment of thromboangiitis obliterans
Disease Area:
Rare Diseases
Source
Source
Scroll to Top